GlycoMimetics
GLYC
#10327
Rank
โ‚ฌ8.7 M
Marketcap
0,13ย โ‚ฌ
Share price
-5.42%
Change (1 day)
-50.78%
Change (1 year)

EPS for GlycoMimetics (GLYC)

EPS in 2025 (TTM): -0,48ย โ‚ฌ

According to GlycoMimetics 's latest financial reports the company's current EPS (TTM) is -0,45ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,76ย โ‚ฌ an increase over its 2021 EPS that were of -1,06ย โ‚ฌ.

EPS history for GlycoMimetics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,48ย โ‚ฌ
2022-0,76ย โ‚ฌ-28.46%
2021-1,06ย โ‚ฌ10.81%
2020-0,95ย โ‚ฌ-17.78%
2019-1,16ย โ‚ฌ14.41%
2018-1,01ย โ‚ฌ
2016-1,30ย โ‚ฌ125.37%
2015-0,58ย โ‚ฌ8.06%
2014-0,53ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
bluebird bio
BLUE
-21,31ย โ‚ฌ 4,671.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,18ย โ‚ฌ-812.63%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-2,107.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-52,39ย โ‚ฌ 11,630.77%๐Ÿ‡บ๐Ÿ‡ธ USA